Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: Changing requirements during the course of inflammation

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4873-4882

  Brown, Meghan N ^a   Fintushel, Sarah R ^a   Lee, Michael H ^a   Jennrich, Silke ^a   Geherin, Skye A ^a   Hay, John B ^b   Butcher, Eugene C ^c,d   Debes, Gudrun F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; FINGOLIMOD; GAMMA INTERFERON; INTERLEUKIN 17; PERTUSSIS TOXIN; SPINGOSINE 1 PHOSPHATE RECEPTOR 1; UNCLASSIFIED DRUG; FORMYLPEPTIDE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; LYMPH; LYMPHOID TISSUE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; ANIMAL; BAGG ALBINO MOUSE; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; SHEEP; SKIN; T LYMPHOCYTE;

ANIMALS; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; INFLAMMATION; MICE; MICE, INBRED BALB C; RECEPTORS, CCR7; RECEPTORS, FORMYL PEPTIDE; SHEEP; SKIN; T-LYMPHOCYTES;

EID: 78049518356     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000676     Document Type: Article

References (63)

1. Campbell, D. J., G. F. Debes, B. Johnston, E. Wilson, and E. C. Butcher. 2003. Targeting T cell responses by selective chemokine receptor expression. Semin. Immunol. 15:277-286.
2. Luster, A. D., R. Alon, and U. H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6:1182-1190.
3. Mackay, C. R., W. L. Marston, and L. Dudler. 1990. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171:801-817.
4. Hall, J. G., and B. Morris. 1965. The origin of the cells in the efferent lymph from a single lymph node. J. Exp. Med. 121:901-910.
5. Chin, W., and J. B. Hay. 1980. A comparison of lymphocyte migration through intestinal lymph nodes, subcutaneous lymph nodes, and chronic inflammatory sites of sheep. Gastroenterology 79:1231-1242.
6. Klonowski, K. D., K. J. Williams, A. L. Marzo, D. A. Blair, E. G. Lingenheld, and L. Lefrançois. 2004. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 20:551-562.
7. Kumar, V., A. K. Abbas, and N. Fausto. 2005. Acute and chronic inflammation. In Robbins and Cotran: Pathologic Basis of Disease. V. Kumar, A. K. Abbas, and N. Fausto, eds. Elsevier Saunders, Philadelphia, PA, p. 47-86.
8. Dardalhon, V., T. Korn, V. K. Kuchroo, and A. C. Anderson. 2008. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 31:252-256.
9. Martinez, G. J., R. I. Nurieva, X. O. Yang, and C. Dong. 2008. Regulation and function of proinflammatory TH17 cells. Ann. N. Y. Acad. Sci. 1143:188-211.
10. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9:970-980.
11. Sigmundsdottir, H., and E. C. Butcher. 2008. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9:981-987.
12. Seabrook, T., B. Au, J. Dickstein, X. Zhang, B. Ristevski, and J. B. Hay. 1999. The traffic of resting lymphocytes through delayed hypersensitivity and chronic inflammatory lesions: a dynamic equilibrium. Semin. Immunol. 11:115-123.
13. Hay, J. B., T. B. Issekutz, and W. G. Chin. 1981. Lymphocyte traffic through chronic inflammatory lesions: relevance to rheumatic diseases. In Immunological Aspects of Rheumatology. C. Dick, ed. MTP Press, Lancaster, PA, p. 29-40.
14. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95:258-263.
15. Saeki, H., A. M. Moore, M. J. Brown, and S. T. Hwang. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162:2472-2475.
16. Nakano, H., and M. D. Gunn. 2001. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J. Immunol. 166:361-369.
17. Salmi, M., K. Koskinen, T. Henttinen, K. Elima, and S. Jalkanen. 2004. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 104:3849-3857.
18. Marttila-Ichihara, F., R. Turja, M. Miiluniemi, M. Karikoski, M. Maksimow, J. Niemelä, L. Martinez-Pomares, M. Salmi, and S. Jalkanen. 2008. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 112:64-72.
19. Johnson, L. A., S. Clasper, A. P. Holt, P. F. Lalor, D. Baban, and D. G. Jackson. 2006. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203:2763-2777.
20. Debes, G. F., C. N. Arnold, A. J. Young, S. Krautwald, M. Lipp, J. B. Hay, and E. C. Butcher. 2005. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6:889-894.
21. Bromley, S. K., S. Y. Thomas, and A. D. Luster. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6:895-901.
22. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346-349.
23. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360.
24. Schwab, S. R., and J. G. Cyster. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8:1295-1301.
25. Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. F. Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer. 2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194:797-808.
26. MartIn-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621.
27. Eberhard, Y., S. Ortiz, A. Ruiz Lascano, R. Kuznitzky, and H. M. Serra. 2004. Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants. BMC Immunol. 5:7.
28. Burman, A., O. Haworth, D. L. Hardie, E. N. Amft, C. Siewert, D. G. Jackson, M. Salmon, and C. D. Buckley. 2005. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J. Immunol. 174:1693-1700.
29. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33.
30. Young, A. J., W. R. Hein, and J. B. Hay. 1997. Cannulation of lymphatic vessels and its use in the study of lymphocyte traffic. In Manual of Immunological Methods: The Comprehensive Source Book of Techniques. I. Levkovits, ed. Academic Press, San Diego, CA, p. 2039-2059.
31. Issekutz, T. B., W. Chin, and J. B. Hay. 1982. The characterization of lymphocytes migrating through chronically inflamed tissues. Immunology 46:59-66.
32. Johnston, M. G., J. B. Hay, and H. Z. Movat. 1979. Kinetics of prostaglandin production in various inflammatory lesions, measured in draining lymph. Am. J. Pathol. 95:225-238.
33. Johnston, M. G., J. B. Hay, and H. Z. Movat. 1980. The distribution of prostaglandins in afferent and efferent lymph from inflammatory sites. Am. J. Pathol. 99:695-714.
34. Smith, J. B., G. H. McIntosh, and B. Morris. 1970. The migration of cells through chronically inflamed tissues. J. Pathol. 100:21-29.
35. Nofer, J. R., M. Bot, M. Brodde, P. J. Taylor, P. Salm, V. Brinkmann, T. van Berkel, G. Assmann, and E. A. Biessen. 2007. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115:501-508.
36. Cinamon, G., M. Matloubian, M. J. Lesneski, Y. Xu, C. Low, T. Lu, R. L. Proia, and J. G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5:713-720.
37. Zabel, B. A., S. Nakae, L. Zúñiga, J. Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S. J. Allen, et al. 2008. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 205:2207-2220.
38. Knibbs, R. N., R. A. Craig, P. Mály, P. L. Smith, F. M. Wolber, N. E. Faulkner, J. B. Lowe, and L. M. Stoolman. 1998. a (1, 3)-Fucosyltransferase VII-dependent synthesis of P-and E-selectin ligands on cultured T lymphoblasts. J. Immunol. 161:6305-6315.
39. Lascelles, A. K., and B. Morris. 1961. Surgical techniques for the collection of lymph from unanaesthetized sheep. Q. J. Exp. Physiol. Cogn. Med. Sci. 46:199-205.
40. Hall, J. G., and B. Morris. 1963. The lymph-borne cells of the immune response. Q. J. Exp. Physiol. Cogn. Med. Sci. 48:235-247.
41. Austrup, F., D. Vestweber, E. Borges, M. Löhning, R. Bräuer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385:81-83.
42. + T cells express functional CCR7. J. Immunol. 168:5441-5447.
43. Brinkmann, V., J. G. Cyster, and T. Hla. 2004. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant. 4:1019-1025.
44. Sensken, S. C., C. Bode, and M. H. Gräler. 2009. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy. J. Pharmacol. Exp. Ther. 328:963-969.
45. Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo, E. A. Moseman, I. V. Huff, T. Junt, A. J. Wagers, I. B. Mazo, and U. H. von Andrian. 2007. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131:994-1008.
46. Ledgerwood, L. G., G. Lal, N. Zhang, A. Garin, S. J. Esses, F. Ginhoux, M. Merad, H. Peche, S. A. Lira, Y. Ding, et al. 2008. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9:42-53.
47. Baluk, P., T. Tammela, E. Ator, N. Lyubynska, M. G. Achen, D. J. Hicklin, M. Jeltsch, T. V. Petrova, B. Pytowski, S. A. Stacker, et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115:247-257.
48. Angeli, V., F. Ginhoux, J. Llodrà, L. Quemeneur, P. S. Frenette, M. Skobe, R. Jessberger, M. Merad, and G. J. Randolph. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203-215.
49. Hall, J. G., and B. Morris. 1962. The output of cells in lymph from the popliteal node of sheep. Q. J. Exp. Physiol. Cogn. Med. Sci. 47:360-369.
50. Young, A. J., W. L. Marston, and L. Dudler. 2000. Subset-specific regulation of the lymphatic exit of recirculating lymphocytes in vivo. J. Immunol. 165:3168-3174.
51. Liao, S., and N. H. Ruddle. 2006. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J. Immunol. 177:3369-3379.
52. Baluk, P., L. C. Yao, J. Feng, T. Romano, S. S. Jung, J. L. Schreiter, L. Yan, D. J. Shealy, and D. M. McDonald. 2009. TNF-a drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J. Clin. Invest. 119:2954-2964.
53. Tabibiazar, R., L. Cheung, J. Han, J. Swanson, A. Beilhack, A. An, S. S. Dadras, N. Rockson, S. Joshi, R. Wagner, and S. G. Rockson. 2006. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 3: e254.
54. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5:617-628.
55. Henning, G., L. Ohl, T. Junt, P. Reiterer, V. Brinkmann, H. Nakano, W. Hohenberger, M. Lipp, and R. Förster. 2001. CC chemokine receptor 7-dependent and-independent pathways for lymphocyte homing: modulation by FTY720. J. Exp. Med. 194:1875-1881.
56. ai-coupled receptors to promote T cell egress. Immunity 28:122-133.
57. low, CCL27-expressing lymphatic endothelial cells. Am. J. Pathol. 173:1202-1209.
58. Uchimura, K., and S. D. Rosen. 2006. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol. 27:559-565.
59. Hjelmström, P., J. Fjell, T. Nakagawa, R. Sacca, C. A. Cuff, and N. H. Ruddle. 2000. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156:1133-1138.
60. Weninger, W., H. S. Carlsen, M. Goodarzi, F. Moazed, M. A. Crowley, E. S. Baekkevold, L. L. Cavanagh, and U. H. von Andrian. 2003. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J. Immunol. 170:4638-4648.
61. + T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 8:743-752.
62. Sawa, Y., and E. Tsuruga. 2008. The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides. J. Anat. 212:654-663. (Pubitemid 351593971)
63. Mancardi, S., E. Vecile, N. Dusetti, E. Calvo, G. Stanta, O. R. Burrone, and A. Dobrina. 2003. Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 108:523-530.